Cours Integrity Applications, Inc. Other OTC
Actions
IGAP
US45824Q1013
Recherche biotechnologique et médicale
CA 2022 | - | CA 2023 | - | Capitalisation | 5,46 M 4,97 M |
---|---|---|---|---|---|
Résultat net 2022 | -4 M -3,64 M | Résultat net 2023 | -7 M -6,37 M | VE / CA 2022 | - |
Trésorerie nette 2022 | 2,12 M 1,93 M | Trésorerie nette 2023 | 4,3 M 3,91 M | VE / CA 2023 | - |
PER 2022 |
-4,92
x | PER 2023 |
-0,68
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 64,57% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Paul Goode
CEO | Chief Executive Officer | 56 | 17/12/20 |
James Cardwell
DFI | Director of Finance/CFO | 64 | 11/10/23 |
David Hammond
CTO | Chief Tech/Sci/R&D Officer | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Drew Sycoff
BRD | Director/Board Member | 57 | 08/07/19 |
Luis J. Malavé
CHM | Chairman | 61 | 13/02 |
Director/Board Member | 95 | 01/01/10 |
Varia. 1 janv. | Capi. | |
---|---|---|
+2,17% | 42,75 Md | |
+47,70% | 41,61 Md | |
+12,23% | 41,34 Md | |
-8,83% | 26,59 Md | |
+6,56% | 25,49 Md | |
-22,92% | 18,12 Md | |
+30,28% | 12,24 Md | |
-2,23% | 11,76 Md | |
+8,99% | 11 Md |